172 related articles for article (PubMed ID: 34581506)
1. Inhibition of JMJD6 by 2-Oxoglutarate Mimics.
Islam MS; Thinnes CC; Holt-Martyn JP; Chowdhury R; McDonough MA; Schofield CJ
ChemMedChem; 2022 Jan; 17(1):e202100398. PubMed ID: 34581506
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of a viral prolyl hydroxylase.
Langley GW; Abboud MI; Lohans CT; Schofield CJ
Bioorg Med Chem; 2019 Jun; 27(12):2405-2412. PubMed ID: 30737136
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6.
Islam MS; McDonough MA; Chowdhury R; Gault J; Khan A; Pires E; Schofield CJ
J Biol Chem; 2019 Jul; 294(30):11637-11652. PubMed ID: 31147442
[TBL] [Abstract][Full Text] [Related]
4. The hydroxylation activity of Jmjd6 is required for its homo-oligomerization.
Han G; Li J; Wang Y; Li X; Mao H; Liu Y; Chen CD
J Cell Biochem; 2012 May; 113(5):1663-70. PubMed ID: 22189873
[TBL] [Abstract][Full Text] [Related]
5. Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylases.
Woon EC; Tumber A; Kawamura A; Hillringhaus L; Ge W; Rose NR; Ma JH; Chan MC; Walport LJ; Che KH; Ng SS; Marsden BD; Oppermann U; McDonough MA; Schofield CJ
Angew Chem Int Ed Engl; 2012 Feb; 51(7):1631-4. PubMed ID: 22241642
[No Abstract] [Full Text] [Related]
6. Discovery of a new class of JMJD6 inhibitors and structure-activity relationship study.
Wang T; Zhang R; Liu Y; Fang Z; Zhang H; Fan Y; Yang S; Xiang R
Bioorg Med Chem Lett; 2021 Jul; 44():128109. PubMed ID: 33991627
[TBL] [Abstract][Full Text] [Related]
7. The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues.
Mantri M; Loik ND; Hamed RB; Claridge TD; McCullagh JS; Schofield CJ
Chembiochem; 2011 Mar; 12(4):531-4. PubMed ID: 22238144
[TBL] [Abstract][Full Text] [Related]
8. Jumonji domain-containing protein 6 protein and its role in cancer.
Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X
Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032
[TBL] [Abstract][Full Text] [Related]
9. Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4.
Konuma T; Yu D; Zhao C; Ju Y; Sharma R; Ren C; Zhang Q; Zhou MM; Zeng L
Sci Rep; 2017 Nov; 7(1):16272. PubMed ID: 29176719
[TBL] [Abstract][Full Text] [Related]
10. The oxygenase Jmjd6--a case study in conflicting assignments.
Böttger A; Islam MS; Chowdhury R; Schofield CJ; Wolf A
Biochem J; 2015 Jun; 468(2):191-202. PubMed ID: 25997831
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.
Holt-Martyn JP; Chowdhury R; Tumber A; Yeh TL; Abboud MI; Lippl K; Lohans CT; Langley GW; Figg W; McDonough MA; Pugh CW; Ratcliffe PJ; Schofield CJ
ChemMedChem; 2020 Feb; 15(3):270-273. PubMed ID: 31751494
[TBL] [Abstract][Full Text] [Related]
12. A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.
Schiller R; Scozzafava G; Tumber A; Wickens JR; Bush JT; Rai G; Lejeune C; Choi H; Yeh TL; Chan MC; Mott BT; McCullagh JS; Maloney DJ; Schofield CJ; Kawamura A
ChemMedChem; 2014 Mar; 9(3):566-71. PubMed ID: 24504543
[TBL] [Abstract][Full Text] [Related]
13. The polyserine domain of the lysyl-5 hydroxylase Jmjd6 mediates subnuclear localization.
Wolf A; Mantri M; Heim A; Müller U; Fichter E; Mackeen MM; Schermelleh L; Dadie G; Leonhardt H; Vénien-Bryan C; Kessler BM; Schofield CJ; Böttger A
Biochem J; 2013 Aug; 453(3):357-70. PubMed ID: 23688307
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates.
Thalhammer A; Mecinović J; Loenarz C; Tumber A; Rose NR; Heightman TD; Schofield CJ
Org Biomol Chem; 2011 Jan; 9(1):127-35. PubMed ID: 21076780
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the 2-oxoglutarate- and Fe(II)-dependent lysyl hydroxylase JMJD6.
Mantri M; Krojer T; Bagg EA; Webby CJ; Butler DS; Kochan G; Kavanagh KL; Oppermann U; McDonough MA; Schofield CJ
J Mol Biol; 2010 Aug; 401(2):211-22. PubMed ID: 20684070
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches.
Rose NR; Woon EC; Kingham GL; King ON; Mecinović J; Clifton IJ; Ng SS; Talib-Hardy J; Oppermann U; McDonough MA; Schofield CJ
J Med Chem; 2010 Feb; 53(4):1810-8. PubMed ID: 20088513
[TBL] [Abstract][Full Text] [Related]
17. Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding.
Thinnes CC; Lohans CT; Abboud MI; Yeh TL; Tumber A; Nowak RP; Attwood M; Cockman ME; Oppermann U; Loenarz C; Schofield CJ
Chemistry; 2019 Feb; 25(8):2019-2024. PubMed ID: 30427558
[TBL] [Abstract][Full Text] [Related]
18. A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo.
Xiao RQ; Ran T; Huang QX; Hu GS; Fan DM; Yi J; Liu W
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2200753119. PubMed ID: 35969736
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure and functional analysis of JMJD5 indicate an alternate specificity and function.
Del Rizzo PA; Krishnan S; Trievel RC
Mol Cell Biol; 2012 Oct; 32(19):4044-52. PubMed ID: 22851697
[TBL] [Abstract][Full Text] [Related]
20. JMJD6 is a histone arginine demethylase.
Chang B; Chen Y; Zhao Y; Bruick RK
Science; 2007 Oct; 318(5849):444-7. PubMed ID: 17947579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
